Breaking News Instant updates and real-time market news.

SGYP

Synergy Pharmaceuticals

$1.60

(0.00%)

06:20
08/07/18
08/07
06:20
08/07/18
06:20

Synergy Pharmaceuticals announces license agreement with Luoxin Pharmaceutical

Synergy Pharmaceuticals announced that the company has entered into a license agreement with Luoxin Pharmaceutical Group Co., Ltd., Shandong providing Luoxin exclusive rights to develop and commercialize Synergy's lead product TRULANCE for the treatment of adults with chronic idiopathic constipation and irritable bowel syndrome with constipation in mainland China, Hong Kong and Macau. Under the terms of the agreement, Synergy will receive an upfront payment of $12M. Synergy is also eligible, in the event that certain regulatory and commercial milestones are met, to receive additional payments of up to $56M in aggregate. In addition, Synergy is eligible to receive tiered royalty payments on aggregate net sales. Luoxin will lead clinical development in China and be responsible for all activities and expenses relating to clinical development, regulatory approval, and commercialization in China. Yafo Capital acted as a financial advisor on this transaction.

SGYP Synergy Pharmaceuticals
$1.60

(0.00%)

11/14/17
BTIG
11/14/17
NO CHANGE
Target $7
BTIG
Buy
Synergy Pharmaceuticals price target lowered to $7 from $11 at BTIG
BTIG analyst Timothy Chiang lowered his price target on Synergy Pharmaceuticals to $7, saying the revision reflects the potential risk of need for additional equity funding by late 2018/early 2019. Chiang notes that the company may be able to access $100M early next year as part of its loan agreement with CRG LP, but it must meet market cap and Trulance sales minimum requirements. The analyst keeps his Buy rating on Synergy Pharmaceuticals, saying the company is in position to benefit from increased payer access for Trulance in 2018 and the potential for an expanded treatment indication for IBS-C.
01/05/18
OPCO
01/05/18
DOWNGRADE
OPCO
Perform
Synergy Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Derek Archila downgraded Synergy Pharmaceuticals to Perform citing the "nagging capital overhang." The analyst sees the potential for additional dilutive financing in 2018 saying the company may not be able to qualify for the third and fourth tranches of funding from the CRG deal. Any additional equity offerings may require a meaningful discount to the current stock price, Archila tells investors in a research note.
01/25/18
WELS
01/25/18
NO CHANGE
WELS
Outperform
Ironwood outlook unchanged after Trulance approval, says Wells Fargo
Wells Fargo analyst David Maris said that Synergy Pharmaceuticals (SGYP) received FDA approval for Trulance for the treatment of irritable bowel syndrome with constipation, to add to the drug's existing approval for chronic idiopathic constipation. Ironwood's (IRWD) Linzess was initially approved in 2012 for both IBS-C and CIC, noted Maris, who said he expected Trulance's approval in IBS-C and is not making any changes to his Ironwood model following the news. He believes Trulance was already being used off label in IBS-C to some degree, but will be watching if the new on-label indication impacts market share, he said. Maris keeps an Outperform rating on Ironwood shares.
01/25/18
BTIG
01/25/18
NO CHANGE
Target $7
BTIG
Buy
Synergy funding worries may be overdone, says BTIG
BTIG analyst Timothy Chiang noted that Synergy Pharmaceuticals (SGYP) announced that Trulance received expanded FDA approval for IBS-C, which puts it more on par with market leader Linzess from Ironwood (IRWD) and Allergan (AGN). He sees Trulance benefiting from increased payor access and believes the company will have sufficient cash in order to gain access to a second loan tranche of $100M expected by next month, stating that funding worries may be overdone. Chiang keeps a Buy rating and $7 price target on Synergy shares.

TODAY'S FREE FLY STORIES

OESX

Orion Energy

$0.80

-0.0501 (-5.89%)

12:44
11/13/18
11/13
12:44
11/13/18
12:44
Recommendations
Orion Energy analyst commentary  »

Orion Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SBUX

Starbucks

$68.05

0.14 (0.21%)

12:41
11/13/18
11/13
12:41
11/13/18
12:41
Periodicals
Starbucks lays off 5%, or 350, corporate employees, Seattle Times reports »

As part of its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MET

MetLife

$46.01

1.29 (2.88%)

12:40
11/13/18
11/13
12:40
11/13/18
12:40
Options
8.2K Metlife Jan 47.5 - 50 call spreads bought for 82c »

8.2K Metlife Jan 47.5 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CKPT

Checkpoint Therapeutics

$2.37

0.19 (8.72%)

12:38
11/13/18
11/13
12:38
11/13/18
12:38
Hot Stocks
Checkpoint Therapeutics director Lindsay Rosenwald buys 100K shares of stock »

Checkpoint Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEAR

Turtle Beach

$15.81

0.56 (3.67%)

12:35
11/13/18
11/13
12:35
11/13/18
12:35
Options
Turtle Beach put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KORS

Michael Kors

$49.26

1.51 (3.16%)

12:34
11/13/18
11/13
12:34
11/13/18
12:34
Hot Stocks
Michael Kors CEO sees double digit revenue growth in 2020 »

Michael Kors Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SBUX

Starbucks

$68.02

0.11 (0.16%)

12:32
11/13/18
11/13
12:32
11/13/18
12:32
Periodicals
Starbucks to lay off 5% of corporate workforce, Dow Jones says »

The layoffs, which total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

VOYA

Voya Financial

$46.22

1.635 (3.67%)

12:29
11/13/18
11/13
12:29
11/13/18
12:29
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NIO

NIO Inc.

$6.77

0.12 (1.80%)

12:25
11/13/18
11/13
12:25
11/13/18
12:25
Options
NIO Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
11/13/18
11/13
12:25
11/13/18
12:25
Conference/Events
William Blair specialty finance analyst holds a group luncheon »

Specialty Finance Analyst…

DVMT

Dell Technologies

$103.00

4.58 (4.65%)

, VMW

VMware

$151.32

3.16 (2.13%)

12:24
11/13/18
11/13
12:24
11/13/18
12:24
Periodicals
Dell considering raising bid for DVMT tracking stock, Reuters says »

Dell Technologies (DVMT)…

DVMT

Dell Technologies

$103.00

4.58 (4.65%)

VMW

VMware

$151.32

3.16 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 11

    Dec

AKRX

Akorn

$6.74

0.02 (0.30%)

, TEVA

Teva

$23.78

0.09 (0.38%)

12:18
11/13/18
11/13
12:18
11/13/18
12:18
Periodicals
Court rules Allergan's patents on Restasis are invalid, Bloomberg reports »

The U.S. Court of Appeals…

AKRX

Akorn

$6.74

0.02 (0.30%)

TEVA

Teva

$23.78

0.09 (0.38%)

AGN

Allergan

$163.97

0.15 (0.09%)

MYL

Mylan

$36.19

0.25 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/13/18
11/13
12:17
11/13/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.51

1.92 (0.70%)

, SPX

S&P 500

$0.00

(0.00%)

12:16
11/13/18
11/13
12:16
11/13/18
12:16
Periodicals
John Kelly may soon depart Trump administration, NBC News reports »

Chief of Staff John Kelly…

SPY

SPDR S&P 500 ETF Trust

$274.51

1.92 (0.70%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/13/18
11/13
12:16
11/13/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$47.77

-2.87 (-5.67%)

12:15
11/13/18
11/13
12:15
11/13/18
12:15
Options
Etsy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$274.18

1.59 (0.58%)

12:13
11/13/18
11/13
12:13
11/13/18
12:13
General news
Trump says New York Times story on North Korea missile bases 'inaccurate' »

President Donald Trump…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$274.18

1.59 (0.58%)

NYT

New York Times

$26.21

-0.135 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$13.58

0.33 (2.49%)

12:11
11/13/18
11/13
12:11
11/13/18
12:11
Hot Stocks
Breaking Hot Stocks news story on Summit Materials »

Southeastern Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,659.40

22.7 (1.39%)

, HD

Home Depot

$176.79

-2.72 (-1.52%)

12:08
11/13/18
11/13
12:08
11/13/18
12:08
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks have endured a…

AMZN

Amazon.com

$1,659.40

22.7 (1.39%)

HD

Home Depot

$176.79

-2.72 (-1.52%)

AAPL

Apple

$195.05

0.895 (0.46%)

QRVO

Qorvo

$63.65

-0.15 (-0.24%)

GE

General Electric

$8.53

0.55 (6.89%)

BHGE

Baker Hughes

$24.40

0.77 (3.26%)

LITE

Lumentum

$39.86

2.355 (6.28%)

JCI

Johnson Controls

$35.65

1.47 (4.30%)

BBU

Brookfield Business Partners

$37.95

1.1 (2.99%)

NVDA

Nvidia

$202.02

12.65 (6.68%)

AAP

Advance Auto Parts

$182.72

15.78 (9.45%)

JKHY

Jack Henry

$139.74

-1.57 (-1.11%)

TSN

Tyson Foods

$58.10

-3.41 (-5.54%)

EPC

Edgewell Personal Care

$43.11

-3.13 (-6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

  • 10

    Dec

  • 03

    Mar

  • 15

    Nov

AMZN

Amazon.com

$1,659.46

22.76 (1.39%)

12:08
11/13/18
11/13
12:08
11/13/18
12:08
Recommendations
Amazon.com analyst commentary  »

Amazon.com HQ2 locations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

UPS

UPS

$110.25

2.51 (2.33%)

12:06
11/13/18
11/13
12:06
11/13/18
12:06
Hot Stocks
UPS adds 14 new countries served by UPS Worldwide Express »

UPS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SBGI

Sinclair Broadcast

$31.54

0.26 (0.83%)

, TRCO

Tribune Media

$39.10

-0.255 (-0.65%)

12:05
11/13/18
11/13
12:05
11/13/18
12:05
Periodicals
Sinclair, Tribune resolve DOJ case over ad sales, Bloomberg says »

Sinclair Broadcast…

SBGI

Sinclair Broadcast

$31.54

0.26 (0.83%)

TRCO

Tribune Media

$39.10

-0.255 (-0.65%)

MDP

Meredith

$56.98

-0.06 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

SWN

Southwestern Energy

$6.04

0.24 (4.14%)

12:05
11/13/18
11/13
12:05
11/13/18
12:05
Options
Southwestern Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ZEN

Zendesk

$53.52

0.32 (0.60%)

, AMZN

Amazon.com

$1,658.41

21.71 (1.33%)

12:03
11/13/18
11/13
12:03
11/13/18
12:03
Hot Stocks
Zendesk launches Sunshine, 'an open and flexible CRM platform' »

Zendesk (ZEN) launched…

ZEN

Zendesk

$53.52

0.32 (0.60%)

AMZN

Amazon.com

$1,658.41

21.71 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 06

    Dec

  • 06

    Dec

  • 12

    Dec

  • 13

    Dec

JBLU

JetBlue

$18.24

0.27 (1.50%)

12:02
11/13/18
11/13
12:02
11/13/18
12:02
Hot Stocks
JetBlue appoints Brandon Nelson general counsel, corporate secretary »

JetBlue announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.